1. Home
  2. IMNM vs KODK Comparison

IMNM vs KODK Comparison

Compare IMNM & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • KODK
  • Stock Information
  • Founded
  • IMNM 2006
  • KODK 1880
  • Country
  • IMNM United States
  • KODK United States
  • Employees
  • IMNM N/A
  • KODK N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • KODK Business Services
  • Sector
  • IMNM Health Care
  • KODK Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • KODK Nasdaq
  • Market Cap
  • IMNM 806.1M
  • KODK 649.6M
  • IPO Year
  • IMNM 2020
  • KODK N/A
  • Fundamental
  • Price
  • IMNM $9.52
  • KODK $7.06
  • Analyst Decision
  • IMNM Strong Buy
  • KODK
  • Analyst Count
  • IMNM 5
  • KODK 0
  • Target Price
  • IMNM $28.60
  • KODK N/A
  • AVG Volume (30 Days)
  • IMNM 1.2M
  • KODK 1.1M
  • Earning Date
  • IMNM 03-27-2025
  • KODK 03-13-2025
  • Dividend Yield
  • IMNM N/A
  • KODK N/A
  • EPS Growth
  • IMNM N/A
  • KODK 0.52
  • EPS
  • IMNM N/A
  • KODK 0.71
  • Revenue
  • IMNM $10,129,000.00
  • KODK $1,052,000,000.00
  • Revenue This Year
  • IMNM N/A
  • KODK N/A
  • Revenue Next Year
  • IMNM N/A
  • KODK N/A
  • P/E Ratio
  • IMNM N/A
  • KODK $9.96
  • Revenue Growth
  • IMNM N/A
  • KODK N/A
  • 52 Week Low
  • IMNM $8.97
  • KODK $3.39
  • 52 Week High
  • IMNM $30.96
  • KODK $8.24
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 40.66
  • KODK 45.69
  • Support Level
  • IMNM $9.67
  • KODK $7.05
  • Resistance Level
  • IMNM $10.68
  • KODK $8.24
  • Average True Range (ATR)
  • IMNM 0.80
  • KODK 0.47
  • MACD
  • IMNM -0.08
  • KODK -0.06
  • Stochastic Oscillator
  • IMNM 0.34
  • KODK 4.07

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

About KODK Eastman Kodak Company Common New

Eastman Kodak Co is a United States-based company. The company operates via several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

Share on Social Networks: